A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis

Completed · Phase 4

Conditions studied: Postmenopausal Osteoporosis

In brief

This study will evaluate participant-reported preference for either ibandronate or a comparator drug in women with postmenopausal osteoporosis. The anticipated time of study treatment is 6 months, and the target sample size is 338 individuals.

Key facts

Study ID

NCT02598440

Run by

Hoffmann-La Roche

People needed

341

Starts

2004-03-01

Expected to finish

2005-05-01

Last updated by the study team

2016-11-02

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Ambulatory women
• Diagnosis of post-menopausal osteoporosis
• Women who have never received bisphosphonate therapy, or who have discontinued daily bisphosphonates at least 3 months prior to study entry

You may not qualify if…

• Inability to stand or sit in the upright position for greater than or equal to 60 minutes
• Allergy to bisphosphonates;
• Previous or current treatment with weekly or monthly bisphosphonates, or daily bisphosphonates for the last 3 months prior to study entry

Where it is running

• Study site — Phoenix, Arizona, United States
• Study site — Tempe, Arizona, United States
• Study site — Laguna Woods, California, United States
• Study site — Mission Viejo, California, United States
• Study site — Oceanside, California, United States
• Study site — San Diego, California, United States
• Study site — San Diego, California, United States
• Study site — Santa Clarita, California, United States
• Study site — Upland, California, United States
• Study site — Vista, California, United States
• Study site — Denver, Colorado, United States
• Study site — Cromwell, Connecticut, United States
• Study site — Waterbury, Connecticut, United States
• Study site — Newark, Delaware, United States
• Study site — Aventura, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Pembroke Pines, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — West Palm Beach, Florida, United States
• Study site — Augusta, Georgia, United States
• Study site — Decatur, Georgia, United States
• Study site — Chicago, Illinois, United States
• Study site — Indianapolis, Indiana, United States
• Study site — South Bend, Indiana, United States
• Study site — Huntsville, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.